-

Robbins LLP Is Investigating the Officers and Directors of Poseida Therapeutics, Inc. (PSTX) on Behalf of Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP is investigating whether Poseida Therapeutics, Inc. (NASDAQ: PSTX) and its officers and directors violated securities laws and engaged in unlawful business practices in connection with its initial public offering ("IPO"). Poseida is a clinical-stage biopharmaceutical company that develops therapeutics for patients with high unmet medical needs.

If you have suffered a loss due to Poseida Therapeutics, Inc.'s misconduct, click here.

Poseida conducted its IPO on July 10, 2020, issuing 14 million shares for $16.00 per share. On August 18, 2020, Poseida announced that the U.S. Food and Drug Administration had placed a clinical hold on its Phase 1 clinical trial evaluating the autologous CAR-T therapy P-PSMA-101 in patients with metastatic castration-resistant prostate cancer due to a patient's death. On this news, Poseida's stock fell 30.31%, to close at $9.06 on August 18, 2020.

Poseida Therapeutics, Inc. (PSTX) Shareholders Have Legal Options

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against Poseida settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Industry:

Robbins LLP

NASDAQ:PSTX
Release Versions
English
$Cashtags
$GNUS
Hashtags
#ClassAction
#Finance
#Investment
#Investor
#Lawsuit
#Securities
#Shareholder
#Shareholderrights
#StockAlert
#StockMarketData
#StockNews
#StockTrading
#Stocks
#Trader
#shareholderrightslawfirm

Contacts

Lauren Levi
Robbins LLP
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the Veritone, Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Veritone, Inc. (NASDAQ: VERI) securities between October 14, 2025 and April 14, 2026. Veritone engages in the provision of artificial intelligence (“AI”) computing solutions and services.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegat...

Stockholder Alert: Robbins LLP Announces that the Shareholder Class Action Against Lamb Weston Holdings, Inc. Survived the Motion to Dismiss

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that Lamb Weston Holdings, Inc. (NYSE: LW) may face damages due to a pending securities class action lawsuit brought on behalf of investors who purchased the Company's securities between July 25, 2023 and April 3, 2024. Lamb Weston is a large producer of frozen potato products, which it sells to restaurants and retailers around the world.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6...

Investor Notice: Robbins LLP Informs Sellers of the ChampionX Corporation. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a class action was filed on behalf of all sellers of ChampionX Corporation (NASDAQ: CHX) common stock between February 29, 2024 and April 1, 2024. ChampionX is a global provider of chemistry solutions, artificial lift systems, and highly engineered equipment and technologies for the drilling and production of oil and gas. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The a...
Back to Newsroom